Translated ClinicalThought

Share

Program Content

Activities

  • 子宫内膜癌 IO
    子宫内膜癌分子学重新分类:确定适合接受免疫治疗的患者
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 26, 2021

    Expires: March 25, 2022

  • 子宮内膜がん IO
    子宮体癌の分子再分類:免疫療法の対象となる患者の特定
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 30, 2021

    Expires: March 29, 2022

  • Cancro endometriale IO
    Riclassificazione molecolare del cancro dellendometrio: identificazione dei pazienti idonei per limmunoterapia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 29, 2021

    Expires: April 28, 2022

  • ICI en CE avanzado/recurrente
    Gestione del tumore endometriale avanzato o ricorrente con inibitori del checkpoint immunitario
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2021

    Expires: July 27, 2022

  • 進行/再発 EC における ICI
    免疫チェックポイント阻害剤を用いた進行・再発子宮体癌治療について
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 28, 2021

    Expires: July 27, 2022

  • ICI 治疗晚期/复发性子宫内膜癌 (EC)
    使用免疫检测点抑制剂治疗晚期或复发性子宫内膜癌
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2021

    Expires: July 28, 2022

  • ICI en CE avanzado/recurrente
    Manejo de cáncer de endometrio avanzado o recurrente con inhibidores de puntos de control inmunológico.
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 29, 2021

    Expires: July 28, 2022

  • Inmunoterapia contra el cáncer de endometrio
    Reclasificación molecular del cáncer de endometrio: Identificación de pacientes elegibles para la inmunoterapia
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022
  • ICI pour les cancers de lendomAtre
    Prise en charge des cancers de la۪endomA tre avanc̩s ou en rechute par les inhibiteurs des points de contrAle immunitaire.
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022
  • Immuno-oncologie du cancer de lendomA tre
    Reclassification moléculaire du cancer de lendomAtre: identification des patientes susceptibles de bA©nA©ficier de limmunothA©rapie.
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

Faculty

cover img faculity

Maria-Pilar Barretina-Ginesta, MD

Associate Professor
Medical Sciences Department
Girona University
Assistant Chief
Medical Oncology Department
Institut Catala D Oncologia
Girona, Spain

cover img faculity

Domenica Lorusso, MD, PhD

Full Professor of Obstetrics and Gynecology
Humanitas University
Head of Gynecology Oncology Medical Unit
Humanitas Hospital San Pio X
Milan, Italy

Supporters

Supported by an educational grant from

GlaxoSmithKline